Pediatric diabetic ketoacidosis and cerebral oedema: a systematic review

Area of Science:

• Pediatric Endocrinology
• Neurology
• Metabolic Disorders

Background:

• Diabetic ketoacidosis (DKA) is a common complication of new-onset type 1 diabetes in children.
• Cerebral edema is a rare but serious complication of DKA, potentially causing permanent neurological damage.
• The exact pathophysiology of DKA-related cerebral edema remains unclear.

Purpose of the Study:

• To review current management strategies for cerebral edema in pediatric DKA.
• To provide an overview of targeted treatment options for DKA-associated cerebral edema.
• To highlight the importance of prompt intervention for DKA-related cerebral edema.

Main Methods:

• Literature review of DKA management and cerebral edema treatment.
• Analysis of existing therapeutic modalities for cerebral edema.
• Synthesis of information on fluid restriction, neuroprotection, and osmotherapy.

Main Results:

• Hyperglycemia and ketosis are key indicators in DKA patients with cerebral edema.
• Standard treatment involves intravenous fluids and insulin.
• Management of cerebral edema may include fluid restriction, ABCs, neuroprotective agents, and osmotherapy (mannitol/hypertonic saline).

Conclusions:

• DKA-related cerebral edema requires prompt and targeted management.
• A combination of strategies, including osmotherapy, may be necessary.
• Further research into the pathophysiology and optimal treatment of DKA-related cerebral edema is warranted.